| CYHB2101013 | 曲前列尼尔注射液 | treprostinil | Injection | Chemical Drugs(4) | Supplementary Application | 2021-02-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2200212 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2022-08-22 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CXSL2400638 | 重组安菲博肽注射液 | Anfibatide | Injection | Biological Products(1) | New Drug Application | 2024-09-25 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2101014 | 曲前列尼尔注射液 | treprostinil | Injection | Chemical Drugs(4) | Supplementary Application | 2021-02-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHL2200065 | 盐酸氨酮戊酸口服溶液用粉末 | aminolevulinic acid hydrochloride | Other | Chemical Drugs(3) | Generic Drug | 2022-08-16 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHS2401143 | 舒更葡糖钠注射液 | sugammadex sodium | Injection | Chemical Drugs(4) | Generic Drug | 2024-04-17 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2140520 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-08-03 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2400016 | 人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products(原4) | Supplementary Application | 2024-01-12 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2140519 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-08-03 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2400015 | 人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products(原4) | Supplementary Application | 2024-01-12 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHS2101873 | 左卡尼汀注射液 | levocarnitine | Injection | Chemical Drugs(4) | Generic Drug | 2021-10-19 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2200211 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2022-08-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CXSL2400639 | 重组安菲博肽注射液 | Anfibatide | Injection | Biological Products(1) | New Drug Application | 2024-09-25 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CXL00527 | 盐酸雷洛昔芬片 | raloxifene hydrochloride | Tablet | Chemical Drugs(2) | New Drug Application | 2001-01-18 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Pending Approval | 2002-03-29 | view |
| CXL00526 | 盐酸雷洛昔芬 | raloxifene hydrochloride | Active ingredient | Chemical Drugs(2) | New Drug Application | 2001-01-18 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2002-04-30 | view |
| CSL20020014 | 重组人干扰素α-2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products(5) | New Drug Application | 2002-04-09 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Approval Completed-Pending Certificated | 2003-02-09 | view |
| CXL01A66 | 注射用低分子量肝素钙 | heparin calcium | Lyophilized | Chemical Drugs(5) | New Drug Application | 2002-01-15 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2003-04-18 | view |
| X0301829 | 重组人干扰素α-2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2003-04-08 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2003-09-19 | view |
| X0301828 | 重组人干扰素α-2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2003-04-08 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2003-09-19 | view |
| X0301831 | 重组人干扰素α-2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2003-04-08 | 合肥兆峰科大药业有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2003-10-23 | view |
